NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Seems like you don't have much confidence in NWBO management.
LP only has one shot and she cannot afford to miss it. Take a look at how hard the first dendritic cell therapy got approval.

After the Advisory Committee voted 17 to 0 in favor of the safety of Provenge and 13 to 4 in favor of the efficacy of Provenge, guess what happened? The FDA still requested additional clinical data in support of the efficacy claim contained in the BLA. If you don't want NWBO to fall into the same ditch, be patient and wait. Negativity can be contagious like disease.

https://www.drugs.com/history/provenge.html